Advanced search
Publication Cover
Current Medical Research and Opinion Volume 20, 2004 - Issue 2
Submit an article Journal homepage
195
Views
27
CrossRef citations to date
0
Altmetric
Research Article

Focus on aripiprazole

Ben Green Consultant Psychiatrist, Cheadle Royal Hospital, and Honorary Senior Lecturer, University of Liverpool, UKCorrespondence[email protected]
Pages 207-213 | Accepted 07 Nov 2004, Published online: 12 Dec 2004

Citations (27)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Min-Hyeon Park, Changsu Han, Chi-Un Pae, Soo-Jung Lee, Ashwin A Patkar, Praksh S Masand & Wolfgang W Fleischhacker. (2011) Aripiprazole treatment for patients with schizophrenia: from acute treatment to maintenance treatment. Expert Review of Neurotherapeutics 11:11, pages 1541-1552.
Read now
Chi-Un Pae. (2009) A review of the safety and tolerability of aripiprazole. Expert Opinion on Drug Safety 8:3, pages 373-386.
Read now
Katrin M. Kirschbaum, Christoph Hiemke & Ulrich Schmitt. (2009) Rotarod Impairment: Catalepsy-Like Screening Test for Antipsychotic Side Effects. International Journal of Neuroscience 119:10, pages 1509-1522.
Read now
MathiasB. Forrester. (2006) Aripiprazole Exposures Reported to Texas Poison Control Centers During 2002–2004. Journal of Toxicology and Environmental Health, Part A 69:18, pages 1719-1726.
Read now

Articles from other publishers (23)

Zofia Rogóż, Kinga Kamińska, Marta Anna Lech & Elżbieta Lorenc-Koci. (2022) N-Acetylcysteine and Aripiprazole Improve Social Behavior and Cognition and Modulate Brain BDNF Levels in a Rat Model of Schizophrenia. International Journal of Molecular Sciences 23:4, pages 2125.
Crossref
Goeun Choi, Huiyan Piao, Sairan Eom & Jin-Ho Choy. (2019) Vectorized Clay Nanoparticles in Therapy and Diagnosis. Clays and Clay Minerals 67:1, pages 25-43.
Crossref
Kouji Fukuyama, Toshiki Hasegawa & Motohiro Okada. (2018) Cystine/Glutamate Antiporter and Aripiprazole Compensate NMDA Antagonist-Induced Dysfunction of Thalamocortical L-Glutamatergic Transmission. International Journal of Molecular Sciences 19:11, pages 3645.
Crossref
Yu Kim, Ha Kim, Ki Hong, Hwa Shin & Byung Choi. (2017) Antidepressant Effects of Aripiprazole Augmentation for Cilostazol-Treated Mice Exposed to Chronic Mild Stress after Ischemic Stroke. International Journal of Molecular Sciences 18:2, pages 355.
Crossref
Darakhshan J. Haleem. (2015) 5-HT1A receptor-dependent control of nigrostriatal dopamine neurotransmission in the pharmacotherapy of Parkinson’s disease and schizophrenia. Behavioural Pharmacology 26:1 and 2 - Special Issue, pages 45-58.
Crossref
Rao N. Malempati. (2015) Aripiprazole Adjunct Treatment in Bipolar I or II Disorder, Depressed State. Journal of Nervous & Mental Disease 203:1, pages 58-64.
Crossref
Young-Min Park. (2014) Low-Dose Manic Switch and High-Dose Antimanic Effect and Extrapyramidal Symptoms by Aripiprazole in a Single Bipolar Patient. American Journal of Therapeutics 21:6, pages e218-e220.
Crossref
Judith Buse, Katja Schoenefeld, Alexander M?nchau & Veit Roessner. (2013) Neuromodulation in Tourette syndrome: Dopamine and beyond. Neuroscience & Biobehavioral Reviews 37:6, pages 1069-1084.
Crossref
Yeon-Ji Oh, Goeun Choi, Young Bin Choy, Je Won Park, Jung Hyun Park, Hwa Jeong Lee, Yeo Joon Yoon, Hee Chul Chang & Jin-Ho Choy. (2013) AripiprazoleMontmorillonite: A New Organic-Inorganic Nanohybrid Material for Biomedical Applications. Chemistry - A European Journal 19:15, pages 4869-4875.
Crossref
Konstantinos N. Fountoulakis, John R. Kelsoe & Hagop Akiskal. (2012) Receptor targets for antidepressant therapy in bipolar disorder: An overview. Journal of Affective Disorders 138:3, pages 222-238.
Crossref
Shunsuke Tanahashi, Satoshi Yamamura, Masanori Nakagawa, Eishi Motomura & Motohiro Okada. (2012) Dopamine D2 and serotonin 5-HT1A receptors mediate the actions of aripiprazole in mesocortical and mesoaccumbens transmission. Neuropharmacology 62:2, pages 765-774.
Crossref
Masahiro Shibasaki, Kazuhiro Kurokawa, Koji Mizuno & Seitaro Ohkuma. (2012) Effect of Aripiprazole on Anxiety Associated With Ethanol Physical Dependence and on Ethanol-Induced Place Preference. Journal of Pharmacological Sciences 118:2, pages 215-224.
Crossref
Hisae Matsuo, Hiroshi Abe, Tetsuya Ikeda, Kosuke Ebihara, Ryuichiro Takeda, Toshikazu Nishimori & Yasushi Ishida. (2011) Effect of Aripiprazole on Methamphetamine-Induced Disruption of Latent Inhibition in Rats. Journal of Behavioral and Brain Science 01:03, pages 167-171.
Crossref
Myung-Ji LeeChul-Eung Kim. (2010) Use of Aripiprazole in Clozapine Induced Enuresis: Report of Two Cases. Journal of Korean Medical Science 25:2, pages 333.
Crossref
Konstantinos N Fountoulakis & Eduard Vieta. (2009) Efficacy and safety of aripiprazole in the treatment of bipolar disorder: a systematic review. Annals of General Psychiatry 8:1.
Crossref
Doris E. Braun, Thomas Gelbrich, Volker Kahlenberg, Richard Tessadri, Josef Wieser & Ulrich J. Griesser. (2009) Conformational polymorphism in aripiprazole: Preparation, stability and structure of five modifications. Journal of Pharmaceutical Sciences 98:6, pages 2010-2026.
Crossref
Doris E. Braun, Thomas Gelbrich, Volker Kahlenberg, Richard Tessadri, Josef Wieser & Ulrich J. Griesser. (2008) Stability of Solvates and Packing Systematics of Nine Crystal Forms of the Antipsychotic Drug Aripiprazole. Crystal Growth & Design 9:2, pages 1054-1065.
Crossref
Taku Nagai, Rina Murai, Kanae Matsui, Hiroyuki Kamei, Yukihiro Noda, Hiroshi Furukawa & Toshitaka Nabeshima. (2008) Aripiprazole ameliorates phencyclidine-induced impairment of recognition memory through dopamine D1 and serotonin 5-HT1A receptors. Psychopharmacology 202:1-3, pages 315-328.
Crossref
Alessandro Musenga, Maria Addolorata Saracino, Domenico Spinelli, Egon Rizzato, Giancarlo Boncompagni, Ernst Kenndler & Maria Augusta Raggi. (2008) Analysis of the recent antipsychotic aripiprazole in human plasma by capillary electrophoresis and high-performance liquid chromatography with diode array detection. Analytica Chimica Acta 612:2, pages 204-211.
Crossref
Chi-Un Pae, Alessandro Serretti, Ashwin A Patkar & Praksh S Masand. (2008) Aripiprazole in the Treatment of Depressive and Anxiety Disorders. CNS Drugs 22:5, pages 367-388.
Crossref
A. Bortolozzi, L. Díaz-Mataix, M. Toth, P. Celada & F. Artigas. (2007) In vivo actions of aripiprazole on serotonergic and dopaminergic systems in rodent brain. Psychopharmacology 191:3, pages 745-758.
Crossref
David L Dunner. (2005) Safety and tolerability of emerging pharmacological treatments for bipolar disorder. Bipolar Disorders 7:4, pages 307-325.
Crossref
Marilyn A Davies, Douglas J. Sheffler & Bryan L. Roth. (2006) Aripiprazole: A Novel Atypical Antipsychotic Drug With a Uniquely Robust Pharmacology. CNS Drug Reviews 10:4, pages 317-336.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.